Adjuvant radiotherapy is often recommended after modified radical mastectomy in breast carcinoma patients to reduce the risk of local and regional recurrence. The decision is typically based on factors indicating a higher risk of recurrence.
Radiotherapy Indications Post-Mastectomy
Adjuvant radiotherapy is generally indicated in cases with:
- Tumour Size: Tumours larger than 5 cm (pT2 or greater based on T-stage) are associated with increased local recurrence risk.
- Positive Margins: Microscopic or macroscopic tumour found at the surgical resection margin necessitates radiotherapy to eliminate residual disease.
- Lymph Node Involvement: Extensive lymph node involvement, typically defined as more than four positive axillary lymph nodes (pN2 or pN3 stage), significantly increases recurrence risk.
ER, PR Status and Radiotherapy
Oestrogen receptor (ER) and Progesterone receptor (PR) status primarily guides the decision for systemic endocrine (hormonal) therapy, especially for ER/PR positive tumours. While ER/PR negative tumours can sometimes be more aggressive systemically, their status alone is not a primary indication for adjuvant radiotherapy after mastectomy when compared to local factors like tumour size, margin status, and lymph node burden. Radiotherapy focuses on controlling local and regional disease.
Identifying the Exception
Based on the established criteria for adjuvant radiotherapy post-mastectomy:
- Tumour size > 5 cm requires radiotherapy.
- Positive margins require radiotherapy.
- More than four positive axillary lymph nodes require radiotherapy.
- ER, PR hormone receptor negative status is primarily related to systemic therapy decisions and is not, by itself, a definitive indication for adjuvant radiotherapy in the same way as the other factors listed. Therefore, it is the exception.
The clinical scenario where adjuvant radiotherapy is generally *not* indicated solely based on the provided options is when the tumour is ER, PR hormone receptor negative, assuming other high-risk factors (size, margins, nodes) are not present or are managed differently.
Important Questions from Neck & Breast Surgery
- Medical management of thyrotoxic crisis includes all of the following EXCEPT:
- First line hormone therapy for post-menopausal woman with metastatic carcinoma breast is:
- All of the following are major subtypes of breast cancer based on Gene array analysis EXCEPT:
- Which of the following statements regarding lymphoedema following breast cancer treatment are correct?
1. Incidence has decreased due to rarely combined therapy of axillary LN dissection and
radiotherapy
2. Precipitating cause like LN metastasis is a major determinant
3. The condition is often painful
4. Oedematous limb is susceptible to bacterial infection
Select the correct answer using the code given below: - No increased relative risk of invasive breast carcinoma based on histopathological examination of benign breast tissue is for all of the following EXCEPT:
